Verano Holdings (VRNO) Depreciation & Amortization (CF) (2021 - 2026)

Verano Holdings' (VRNO) quarterly Depreciation & Amortization (CF) came in at $29.2 million in Q1 2026, down 8.19% year-on-year from $31.8 million in Q1 2025, and little changed on a QoQ basis from $29.3 million in Q4 2025.

Verano Holdings (VRNO) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $29.2 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 8.19% year-over-year to $29.2 million in Q1 2026; TTM through Mar 2026 was $121.6 million, a 10.56% decrease from a year earlier, with the FY2025 full-year figure at $124.2 million, down 11.1% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $29.2 million, roughly flat from $29.3 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for VRNO reached as high as $36.9 million in Q3 2024 and fell as low as $29.2 million in Q1 2026.
  • Historically, Depreciation & Amortization (CF) has averaged $33.9 million across 5 years, with a median of $35.2 million in 2022.
  • Across the five-year window, Depreciation & Amortization (CF) jumped 46.15% in 2022 and retreated 14.39% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $35.2 million in 2022, then grew by 1.19% to $35.6 million in 2023, then slipped by 11.41% to $31.5 million in 2024, then retreated by 6.97% to $29.3 million in 2025, then slipped by 0.44% to $29.2 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $29.2 million in Q1 2026, $29.3 million in Q4 2025, and $31.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 29.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.19 Mn
Mar 31, 2026 29.19 Mn
Dec 31, 2025 29.32 Mn
Dec 31, 2025 29.32 Mn
Sep 30, 2025 31.56 Mn
Sep 30, 2025 31.56 Mn
Jun 30, 2025 31.49 Mn
Jun 30, 2025 31.49 Mn
Mar 31, 2025 31.79 Mn
Mar 31, 2025 31.79 Mn
Dec 31, 2024 31.51 Mn
Dec 31, 2024 31.51 Mn
Sep 30, 2024 36.87 Mn
Sep 30, 2024 36.87 Mn
Jun 30, 2024 35.73 Mn
Jun 30, 2024 35.73 Mn
Mar 31, 2024 35.55 Mn
Mar 31, 2024 35.55 Mn
Dec 31, 2023 35.57 Mn
Dec 31, 2023 35.57 Mn